Learn about the practical steps necessary to set up an ED naloxone distribution program. Experts from across the U.S. who have helped establish ED naloxone distribution programs will share their experiences and insights into the key policy and logistical considerations to understand before starting a program in your ED, sharing lessons that they have learned along the way.
At the end of the webinar, participants will be able to take away a set of concrete recommendations and proven best practices, allowing them to set up their own ED naloxone distribution programs.
To sign up, register here: https://attendee.gotowebinar.com/register/5839727624803344642
Webinar ID: 103-133-779
For more information, you can contact: firstname.lastname@example.org.
Edward Bernstein, MD, FACEP—Professor of Emergency Medicine and Director of the Brief Negotiated Interview & Active Referral to Treatment (BNI-ART) Institute at Boston University Medical Center (BUMC). Dr. Bernstein, an innovator in public health and substance abuse research, helped develop the new BMC policy and procedure for the distribution of take-home intranasal naloxone and overdose education for ED patients at risk for opioid overdose.
Margaret Greenwood-Ericksen, MD — A Chief Resident at the Harvard Affiliated Emergency Medicine Residency program who plans to pursue a career in academic emergency medicine with a focus on public health and health care policy. She led the development of the ED naloxone distribution program at Massachusetts General Hospital, and one of her current research interests is optimizing prescription drug monitoring programs (PDMPs) for use in the ED setting. She has published on this topic, and has been awarded EMF/EMRA funding to perform a policy analysis of state PDMPs.
Jason Hoppe, DO — Associate Professor at the University of Colorado School of Medicine and faculty at the Rocky Mountain Poison and Drug Center (RMPDC). His primary area of focus is in prescription drug opioid safety and prescribing decisions. He is the co-chair of Colorado’s Prescription Drug Monitoring Program work group and serves on the coordinating committee for the Colorado Consortium for Prescription Drug Abuse Prevention a statewide collaboration between the Governor’s office, the Department of Public Health and the University of Colorado.
Steven Nikolsky, MSW, LICSW — Behavioral Health and Clinical Social Work Manager at South Shore Hospital for over 10 years. He is a graduate of the Boston University School of Social work, is licensed to practice in Massachusetts and Florida, and specializes in mental health and substance abuse services. He has been very involved with the problems faced within Massachusetts with the Emergency Room boarding issues and the development of SBIRT programs in different areas of acute care hospitals.
Joan Papp, MD, FACEP — Assistant Professor in the Department of Emergency Medicine at MetroHealth Medical Center and Medical Director for the MetroHealth Cuyahoga County Project DAWN program. Project DAWN is an opioid education and naloxone distribution program that naloxone to at risk drug users and to those in a position to rescue them. Dr. Papp serves on the U.S. Attorney’s office Heroin Task Force and is co-chair of the Policy subcommittee, which meets monthly to address opioid policy related issues.
Elizabeth Samuels, MD MPH — A Chief Resident in the Emergency Medicine Residency Program at the Alpert Medical School of Brown University. In 2014, she designed and implemented the Lifespan Opioid Overdose Prevention (LOOP) Program, which distributes naloxone to patients at risk of opioid overdose and their loved ones as well as consultation with a peer recovery coach for outpatient addiction recovery support. She is supported by a NIDA-EMF Training Award in Drug Abuse and Addiction to study LOOP Program feasibility and utilization.
Lauren Whiteside, MD, MS — Assistant Professor in the Division of Emergency Medicine at the University of Washington. She has an academic interest in injury and substance use and does research at the intersection of substance abuse, mental health and acute care trauma with a specific interest in screening and interventions for prescription opioid misuse initiated from the ED. She is the co-investigator for a NIDA-funded study determining the efficacy of opioid overdose education and take-home naloxone among patients in the ED presenting with risk for opioid overdose and is the Principal Investigator of a pilot project looking at the feasibility of a collaborative care intervention for patients presenting to the ED for trauma that also have prescription drug misuse